艾伯科技(02708.HK)斥4,000萬元投資一芯微科技 有權增資
艾伯科技(02708.HK)公布,其間接全資附屬公司艾伯智能(深圳)有限公司向一芯微科技投資一筆相等於4,000萬港元的人民幣金額,以持有其5%股本;及待重組完成後,公司享有權利進行進一步投資,令集團持有35%至46%股本。
集團指,一芯微科技重組完成後,公司享有權利選擇以不超過每股1.50元的發行價發行股份、可轉股債券、承兌票據及現金或其他工具,以收購創辦人間接持有的海外控股公司及一芯微科技股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.